Skip to main content
OpenTrials
Completed

NCT Number: NCT02960256

The Impact of Infectious Disease on QT Segment

Sepsis related to the development of cardiac complications. However, the investigators understanding regarding this condition remains incomplete. Possible explanations raised include coronary perfusion decrease, activation of the coagulation system and release of inflammatory mediators, including endotoxins, cytokines and others.

In this study the investigators wanted to examine the impact of any infectious disease, (not necessarily Pneumonia), on the QT interval in patients hospitalized for acute infectious disease.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Internal ward hospitalized patient, due to illness which its etiology is bacterial, fungal or viral

Exclusion criteria

  • Can not technically perform reliably ECG (amputated legs, lack of cooperation, etc.)
  • Subject with permanent pacemaker

Treatment and study plan

ekocardiogram test

Device

ekocardiogram test

Primary outcomes

  1. Prolongation of the QT

    Time frame: 5 days

    QT will be measured by ECG

Sponsors and collaborators

Lead sponsor

HaEmek Medical Center, Israel

Other

Registry information

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Nov 9, 2016
Registry last updated
Mar 14, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.